Selection of proper candidates with resected pathological stage IIIA‐N2 non‐small cell lung cancer for postoperative radiotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1759-7714|6|3|346-353

ISSN： 1759-7706

Source： Thoracic Cancer, Vol.6, Iss.3, 2015-05, pp. : 346-353

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reappraisal of the role of postoperative radiation therapy in patients with pIIIa‐N2 non‐small cell lung cancer: A propensity score matching analysis

By  

Thoracic Cancer, Vol. 6, Iss. 5, 2015-09 ,pp. : 570-578

John Wiley & Sons Inc

Access to resources Recommend Favorite

Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non‐small cell lung cancer patients

By  

Thoracic Cancer, Vol. 6, Iss. 5, 2015-09 ,pp. : 620-628

John Wiley & Sons Inc

Access to resources Recommend Favorite

Platelet‐to‐lymphocyte ratio predicts the prognosis of patients with non‐small cell lung cancer treated with surgery and postoperative adjuvant chemotherapy

By  

Thoracic Cancer, Vol. 9, Iss. 1, 2018-01 ,pp. : 112-119

John Wiley & Sons Inc

Access to resources Recommend Favorite

Percutaneous radiofrequency ablation for medically inoperable patients with clinical stage I non‐small cell lung cancer

By  

Thoracic Cancer, Vol. 6, Iss. 3, 2015-05 ,pp. : 327-333

John Wiley & Sons Inc

Access to resources Recommend Favorite

CRTC2 promotes non‐small cell lung cancer A549 migration and invasion in vitro

By  

Thoracic Cancer, Vol. 9, Iss. 1, 2018-01 ,pp. : 136-141

John Wiley & Sons Inc

Access to resources Recommend Favorite